Skip to main content

Table 2 Genes identified by SAM that are differentially expressed in Pleural vs. Peritoneal Effusions

From: Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients

Positive Significant Genes: Higher in pleural vs. ascites

NR4A1: nuclear receptor subfamily 4, group A, member 1: Hs.1119

CYR61: cysteine-rich, angiogenic inducer, 61: Hs.8867

CXCL2: chemokine (C-X-C motif) ligand 2: Hs.75765

RAB21: member RAS oncogene family: Hs.184627

CTGF: connective tissue growth factor: Hs.75511

CXCL3: chemokine (C-X-C motif) ligand 3: Hs.89690

TCEB3: transcription elongation factor B (SIII): Hs.155202

IGLL1: immunoglobulin lambda-like polypeptide 1: Hs.348935

CTGF: connective tissue growth factor: Hs.75511

IGHG3: immunoglobulin heavy constant gamma 3: Hs.413826

C1QB: complement component 1, q subcomponent beta: Hs.8986

CYR61: cysteine-rich, angiogenic inducer, 61: Hs.8867

C1QG: complement component 1, q subcomponent gamma:Hs.94953

TAGLN: transgelin: Hs.433399

CD163: Hs.74076

GSTA4: glutathione S-transferase A4: Hs.169907

Negative Significant Genes: Lower in pleural vs. ascites

N33: Putative prostate cancer tumor suppressor: Hs.71119 100791

PLEC1: plectin 1, intermediate filament binding protein 500 kDa: Hs.79706

SLC40A1: solute carrier family 40, member 1: Hs.5944